← Every company
Relay Therapeutics Inc Planned Sales
Before an insider at Relay Therapeutics Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
RLAY insider trades →Notices on file
2
Insiders
2
Shares noticed
189.6K
permission to sell, not sales
Estimated value
$3.6M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Patel SanjivDirector, Officer2026-10-0796.4K sh0.04% | $1.8M |
| Catinazzo ThomasOfficer2026-10-0693.2K sh0.04% | $1.8M |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on RLAY
Company overviewEverything on RLAY in one place, with the price.SEC filingsWhat RLAY's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat RLAY's own officers and directors buy and sell.Executive payWhat RLAY awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in RLAY.Funds holding itWhich funds and ETFs hold RLAY, and how big a bet.PatentsWhat RLAY is filing at the patent office.